Sertraline and Argatroban: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordArgatroban
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Taking sertraline with argatroban can raise your chance of bleeding. Argatroban is a blood thinner, and sertraline (an antidepressant) makes your platelets a little less able to help your blood clot. Put together, that means bruises, nosebleeds, or bleeding may happen more easily, and it can take longer to stop.
This isn't a reason to panic, and you should not stop either medicine on your own. Watch for things like easy bruising, nosebleeds, pink or red urine, black stools, or bleeding that won't quit, and tell your care team right away. Your doctor and pharmacist can watch you closely and keep both medicines working safely.
Effect: Additive bleeding risk when sertraline is combined with argatroban, a direct thrombin inhibitor.
Mechanism: SSRIs deplete platelet serotonin, impairing serotonin-mediated platelet aggregation (a pharmacodynamic effect). Combined with argatroban's anticoagulant action, hemostasis is further compromised. Neither drug is a prodrug; this is a PD, not PK, interaction.
- Direction: Increased bleeding risk (additive).
- Onset: Delayed.
- Evidence: Probable (case-control/cohort data on SSRI plus anticoagulant).
- Severity: Major.
Management: Monitor for bleeding (epistaxis, ecchymosis, hematoma, petechiae, GI/intracranial hemorrhage). Follow aPTT/coagulation and hemoglobin per argatroban protocol; counsel patient on bleeding signs. Doses individualized by the care team.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and warn patients regarding the elevated bleeding risk.1. Platelet release of serotonin plays a key role in preserving hemostasis. Studies using case-control and cohort designs have demonstrated that using SSRIs (like sertraline) together with anticoagulants is linked to a greater bleeding risk 231. Taking sertraline alongside an anticoagulant can heighten the likelihood of bleeding. The bleeding events that have been reported include epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. This combination is manageable with attention and monitoring.
- Your team may watch you more closely for bleeding, including checking bloodwork while you are on argatroban.
- Doses may be adjusted and individualized by your care team based on how you respond.
- Watch for and promptly report: nosebleeds, easy bruising, blood in urine or stool, black stools, unusual gum bleeding, or any bleeding that won't stop.
Ask your pharmacist before adding any new medicine, including aspirin, NSAIDs like ibuprofen, or other blood thinners, since these can add to the risk.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) reported a heightened risk of clinically relevant bleeding (hospital admission because of bleeding) among patients taking warfarin for atrial fibrillation while also receiving SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched against randomly chosen patients who received warfarin alone (n=117). The SSRIs included FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes over 213.9 treatment years, while in the warfarin-only group, 10 patients had 14 bleedings over 586.4 treatment years. The corresponding overall bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. Compared with warfarin alone, the hazard ratio for first bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009). The SSRIs involved in patients who bled during concomitant use were sertraline or citalopram. Adding an SSRI was not linked to a change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study findings may be limited by prior bleeding events, uncertain patient adherence, and the exclusion of clopidogrel, dipyridamol, corticosteroids, and anticoagulants other than warfarin from the model 2.
b) A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) taking selective serotonin reuptake inhibitors (SSRIs) at the same time found an elevated risk of hospitalization due to non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also taking a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients receiving SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) In a non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers, the influence of sertraline on the plasma protein binding of warfarin was evaluated. On days and 32 of the study, all participants received warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or the placebo group; the sertraline dose was gradually increased from 50 mg/day to 200 mg/day. Prothrombin time was measured before each dose of warfarin and at intervals afterward. The investigators concluded that sertraline did not augment the anticoagulant effects of warfarin to a clinically significant degree, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown a link between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events related to SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Argatroban together?
Using sertraline with argatroban adds up to a higher bleeding risk, so keep taking both as prescribed but report any unusual bleeding or bruising to your care team promptly. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Argatroban interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Argatroban interaction managed?
Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. This combination is manageable with attention and monitoring. Your team may watch you more closely for bleeding, including checking bloodwork while you are on argatroban. Doses may be adjusted and individualized by your care team based on how you respond. Watch for and promptly report: nosebleeds, easy brui… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Argatroban need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Argatroban
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist